WHO might give nod for Covaxin this month

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use
Read Article

The World Health Organization’s approval for the COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to come this month, official sources said yesterday.

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.

Covaxin is one of the six vaccines that have received emergency use authorisation from India’s drug regulator and is being used in the nationwide inoculation programme, alongwith Covishield and Sputnik V.

“The WHO approval for Covaxin is likely this month,” an official source said.

COVAXINCovid 19 vaccineCovishieldemergency use authorisationJ&JModernaPfizer-BioNTech COVID-19 vaccineSinopharmSputnik VWHO
Comments (0)
Add Comment